TIAA Trust National Association Has $19.64 Million Position in Elevance Health, Inc. $ELV

TIAA Trust National Association lifted its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 1,038.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 56,020 shares of the company’s stock after acquiring an additional 51,098 shares during the period. TIAA Trust National Association’s holdings in Elevance Health were worth $19,638,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Rossby Financial LCC lifted its position in shares of Elevance Health by 110.0% during the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company’s stock valued at $28,000 after acquiring an additional 44 shares during the period. ORG Partners LLC lifted its position in shares of Elevance Health by 120.4% during the 4th quarter. ORG Partners LLC now owns 108 shares of the company’s stock valued at $38,000 after acquiring an additional 59 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of Elevance Health during the 4th quarter valued at $38,000. Dorato Capital Management acquired a new position in shares of Elevance Health during the 4th quarter valued at $41,000. Finally, Flagship Harbor Advisors LLC acquired a new position in shares of Elevance Health during the 4th quarter valued at $44,000. Institutional investors and hedge funds own 89.24% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Leerink Partners set a $364.00 target price on shares of Elevance Health in a research report on Thursday, April 23rd. Bank of America upped their price objective on shares of Elevance Health from $435.00 to $460.00 and gave the stock a “buy” rating in a report on Thursday, June 4th. JPMorgan Chase & Co. upped their price objective on shares of Elevance Health from $411.00 to $476.00 and gave the stock an “overweight” rating in a report on Monday. Sanford C. Bernstein upped their price objective on shares of Elevance Health from $384.00 to $424.00 and gave the stock an “outperform” rating in a report on Friday, April 24th. Finally, UBS Group upped their price objective on shares of Elevance Health from $400.00 to $460.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $416.11.

Elevance Health Stock Performance

ELV opened at $424.16 on Wednesday. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.70. The company’s fifty day moving average price is $360.00 and its two-hundred day moving average price is $343.26. Elevance Health, Inc. has a 1-year low of $273.71 and a 1-year high of $426.66. The company has a market cap of $92.11 billion, a price-to-earnings ratio of 18.04, a PEG ratio of 2.36 and a beta of 0.67.

Elevance Health (NYSE:ELV) last announced its earnings results on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, beating the consensus estimate of $10.74 by $1.84. The company had revenue of $49.49 billion during the quarter, compared to the consensus estimate of $48.21 billion. Elevance Health had a net margin of 2.62% and a return on equity of 15.58%. The firm’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $11.97 earnings per share. Elevance Health has set its FY 2026 guidance at 19.850- EPS. On average, analysts expect that Elevance Health, Inc. will post 26.94 EPS for the current fiscal year.

Elevance Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be issued a $1.72 dividend. The ex-dividend date is Wednesday, June 10th. This represents a $6.88 annualized dividend and a dividend yield of 1.6%. Elevance Health’s dividend payout ratio is currently 29.26%.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.